文献速递青光眼白内障与屈光手术

小梁手术联合白内障手术治疗开角型青光眼:美国眼科学会报告

Trabecular Procedures Combined with Cataract Surgery for Open-Angle Glaucoma: A Report by the American Academy of Ophthalmology.
PubMed 文献 · Ophthalmology · 2023-12-06

美国眼科学会系统检索PubMed文献(截至2023年4月)并筛选出10项I级随机对照试验,评估小梁手术联合白内障手术对比单纯白内障手术的降眼压效果与安全性。结果显示在高血压性轻中度开角型青光眼患者中,联合手术在2年时较单纯白内障手术额外降低眼压1.6至2.3 mmHg(额外降低3.8%至8.9%),但各小梁手术之间无明确优劣。

要点

  • 联合小梁手术较单纯白内障手术额外降低眼压1.6至2.3 mmHg(额外降低3.8%至8.9%)。
  • 各小梁手术之间无明确优劣,选择可考虑葡萄膜炎倾向、出血风险、金属过敏及Schlemm管狭窄。
  • 尚无I级数据支持小梁手术在治疗前眼压≤21 mmHg患者中的疗效。

核心结论

  • 在高血压性开角型青光眼患者中,小梁手术联合白内障手术较单纯白内障手术提供额外的轻度眼压降低。
  • 需要进一步研究以标准化结局定义、避免行业赞助偏倚,并研究这些手术在眼压正常开角型青光眼患者中的疗效。

研究设计与样本

  • 美国眼科学会通过面板方法学专家对PubMed数据库2021年2月初检、2023年4月更新的英文同行评议文献进行系统评估。
  • 初检获得279篇文章,20项研究符合初始纳入和排除标准,其中10项为I级、3项为II级、7项为III级。
  • 本评估仅纳入10项I级随机对照试验,所有试验均存在潜在的行业赞助偏倚。

主要发现

  • 在进行了药物洗脱的研究中,联合小梁手术在2年时较单纯白内障手术额外降低眼压1.6至2.3 mmHg(额外降低3.8%至8.9%)。
  • 单纯白内障手术本身在2年时降低眼压约5.4至7.6 mmHg(降低21%至28%)。
  • 各小梁手术之间无明确优劣。
  • 选择手术时可考虑的患者特异性因素包括葡萄膜炎倾向、出血风险、金属过敏及Schlemm管狭窄。
  • 尚无I级数据支持小梁手术在治疗前眼压≤21 mmHg患者中的疗效。

关键数值与推荐

  • 在高血压性轻中度开角型青光眼患者中,联合小梁手术较单纯白内障手术额外降低眼压1.6至2.3 mmHg(额外降低3.8%至8.9%)。
  • 单纯白内障手术降低眼压约5.4至7.6 mmHg(降低21%至28%)。
  • 各小梁手术之间无明确优劣。
  • 选择手术时可考虑葡萄膜炎倾向、出血风险、金属过敏及Schlemm管狭窄。
  • 尚无I级数据支持小梁手术在治疗前眼压≤21 mmHg患者中的疗效。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 本评估仅纳入10项I级随机对照试验,所有试验均存在潜在的行业赞助偏倚。
  • 需要进一步研究以标准化结局定义、避免行业赞助偏倚,并研究这些手术在眼压正常开角型青光眼患者中的疗效。
  • 尚无I级数据支持小梁手术在治疗前眼压≤21 mmHg患者中的疗效。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To determine the intraocular pressure (IOP) reduction of various trabecular procedures (a form of minimally invasive glaucoma surgery [MIGS]) combined with cataract surgery compared with cataract surgery alone, to compare the safety of the various trabecular procedures, and to highlight patient characteristics that may favor one trabecular procedure over another. METHODS: A search of English-language peer-reviewed literature in the PubMed database was initially conducted in February 2021 and updated in April 2023. This yielded 279 articles. Twenty studies met initial inclusion and exclusion criteria and were assessed for quality by the panel methodologist. Of these, 10 were rated level I, 3 were rated level II, and 7 were rated level III. Only the 10 level I randomized controlled trials (RCTs) were included in this assessment, and all were subject to potential industry-sponsorship bias. RESULTS: The current analysis focuses on the amount of IOP reduction (in studies that involved medication washout) and on IOP reduction with concurrent medication reduction (in studies that did not involve medication washout). Based on studies that performed a medication washout, adding a trabecular procedure to cataract surgery provided an additional 1.6 to 2.3 mmHg IOP reduction in subjects with hypertensive, mild to moderate open-angle glaucoma (OAG) at 2 years over cataract surgery alone, which itself provided approximately 5.4 to 7.6 mmHg IOP reduction. In other words, adding a trabecular procedure provided an additional 3.8% to 8.9% IOP reduction over cataract surgery alone, which itself provided 21% to 28% IOP reduction. There was no clear benefit of one trabecular procedure over another. Patient-specific considerations that can guide procedure selection include uveitis predisposition, bleeding risk, metal allergy, and narrowing of Schlemm's canal. There are no level I data on the efficacy of trabecular procedures in subjects with pretreatment IOP of 21 mmHg or less. CONCLUSIONS: Trabecular procedures combined with cataract surgery provide an additional mild IOP reduction over cataract surgery alone in hypertensive OAG subjects. Additional research should standardize outcome definitions, avoid industry sponsorship bias, and study the efficacy of these procedures in normotensive OAG. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Richter GM, Takusagawa HL, Sit AJ, et al. Trabecular Procedures Combined with Cataract Surgery for Open-Angle Glaucoma: A Report by the American Academy of Ophthalmology. Ophthalmology. 2023. PMID: 38054909. doi:10.1016/j.ophtha.2023.10.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。